Archive for the ‘News’ Category

Our Fight Moves Forward!

Posted By on December 11th, 2019 at 12:10 pm | 0 comments.

You did it! YOU made it happen.

Legislation requiring insurers to cover breast cancer screenings like ultrasound or MRI for women with high-risk factors, including dense breast tissue, now goes to the full Senate for a vote. The Senate Banking and Insurance Committee unanimously reported Sen. Bob Mensch’s Senate Bill 595 out of committee as amended. From here, the bill goes to the Senate floor.

Senate Bill 595 covers ultrasound or MRI screenings for women with extremely dense breasts and women with heterogeneously dense breasts who have one other high-risk factor. High-risk factors include personal history of breast cancer, family history, positive genetic testing results, among others. 45 out of 49 state senators co-sponsored the bill.

Click here to read Senate Bill 595

 

Study: Women with Early-Stage Breast Cancer May Not Need Chemotherapy

Posted By on June 5th, 2018 at 9:36 am | 0 comments.

According to a recent study, thousands of women with early-stage breast cancer do not need chemotherapy as part of their treatment regimen. The results of the largest ever breast cancer treatment trial, the TAILORx study, were published this week in the New England Journal of Medicine. Researchers say the trial found evidence that 70 percent of early-stage breast cancer patients will receive no benefit from chemotherapy. The article goes on to say those patients would effectively be treated with endocrine therapy alone. The data indicated that some women 50 and younger might benefit from chemo even if gene-test results suggested otherwise. It is not clear why.

“This is a game-changer. It’s truly groundbreaking. Now, thousands of women will not have to undergo toxic chemotherapy treatment with its unwanted side effects,” said PBCC President and Founder Pat Halpin-Murphy. “The results of this clinical trial will change the way oncologists treat breast cancer every day here in Pennsylvania and across the country.”

In order to conduct the TAILORx study, researchers examined results of the Genomic Health Oncotype DX test which provides a score for the patient’s risk of recurrence. The clinical trial found that, in patients who received a score of 11 to 25, chemotherapy was not necessary. Investigators conducted gene tests on tumor samples to identify women who could skip chemo and take drugs like tamoxifen that block estrogen or stop the body from producing estrogen (endocrine therapy). Drugs like tamoxifen have been proven to reduce the risk of recurrence in breast cancer survivors.

Today, 37 women will be diagnosed with breast cancer in Pennsylvania, and 140,000 PA women are currently living with the disease. Early-stage breast cancer makes up half of all breast cancer diagnoses.

CLICK HERE to read the complete New England Journal of Medicine article.

 

Lancaster City Police K-9 Unit Takes a “Bite Out of Breast Cancer”

Posted By on January 16th, 2018 at 2:26 pm | 0 comments.

Taking a Bite Out of Cancer, the Lancaster City Police K-9 and Mounted Units held a special fundraiser for the PA Breast Cancer Coalition in October 2017. Officers sold pink t-shirts in honor of breast cancer awareness month, with a portion of proceeds benefiting the PBCC’s life-saving work throughout the state. The first annual campaign was a doggone success, with a total of $562 going to our programs and services for breast cancer survivors in PA! The PBCC staff was thrilled when the K-9 unit stopped by our office to deliver the donation with dogs in tow! Thank you to Officers Alexander, Reppert, Hatfield and Bradley for bringing K-9s Axel, Stryker, Zoltan and Wodan to our headquarters in Lebanon for this presentation, and to Sargent Michael Gerace for spearheading this unique campaign! The PBCC is honored to be the recipients of this meaningful gift.